Combined liver-kidney and kidney-alone transplantation in primary hyperoxaluria

Carla G. Monico, Dawn S. Milliner

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Combined liver-kidney and kidney-only transplantation outcomes in primary hyperoxaluria (PH) are described. Strategies for the selection of type and timing of transplantation and pretransplantation and posttransplantation management are reviewed. Records were reviewed for 16 patients with PH who received 9 liver-kidney and 10 kidney-only transplants. Plasma oxalate values declined from 61 ± 42 μmol/L pretransplantation to 9 ± 6 μmol/L 1 month after transplantation in liver-kidney transplant recipients and 92 ± 19 to 9 ± 5 μmol/L in kidney-only transplant recipients. In most liver-kidney transplant recipients, hyperoxaluria persisted for 6 to 18 months after transplantation. Follow-up was 3.5 ± 4.1 years in liver-kidney and 4.5 ± 6.3 years in kidney-alone transplant recipients. Patient survival rates were 78% for liver-kidney and 89% for kidney-only transplant recipients. No hepatic allografts were lost. Three of 9 liver-kidney and 6 of 10 kidney-alone transplants lost renal allograft function. In those with functioning kidneys, renal clearance was 45.1 ± 19.5 mL/min/1.73 m2 in liver-kidney transplant recipients and 49.5 ± 26.1 mL/min/ 1.73 m2 in kidney-only transplant recipients at last follow-up. Kaplan-Meier 1-, 2-, 3-, and 5-year renal allograft survival rates for patients undergoing transplantation after 1984 were 78%, 78%, 52%, and 52% in liver-kidney transplant recipients and 86%, 71%, 54%, and 36% in kidney-only transplant recipients. Simultaneous grafting of liver and kidney after the development of renal insufficiency is recommended for the majority of patients with PH type I (PH-I). Kidney-alone transplantation is recommended for those with pyridoxine-responsive type I disease because pharmacological therapy allows favorable management of oxalate production in this situation. Kidney-alone transplantation also is recommended for PH type II (PH-II). This disease is less severe than PH-I, and it is currently unknown whether liver transplantation will correct the metabolic defect responsible for PH-II.

Original languageEnglish (US)
Pages (from-to)954-963
Number of pages10
JournalLiver Transplantation
Volume7
Issue number11
DOIs
StatePublished - 2001

Fingerprint

Primary Hyperoxaluria
Kidney Transplantation
Kidney
Liver
Liver Transplantation
Allografts
Oxalates
Transplantation
Survival Rate

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Combined liver-kidney and kidney-alone transplantation in primary hyperoxaluria. / Monico, Carla G.; Milliner, Dawn S.

In: Liver Transplantation, Vol. 7, No. 11, 2001, p. 954-963.

Research output: Contribution to journalArticle

Monico, Carla G. ; Milliner, Dawn S. / Combined liver-kidney and kidney-alone transplantation in primary hyperoxaluria. In: Liver Transplantation. 2001 ; Vol. 7, No. 11. pp. 954-963.
@article{934accd93b4143c1bc26f469e8481453,
title = "Combined liver-kidney and kidney-alone transplantation in primary hyperoxaluria",
abstract = "Combined liver-kidney and kidney-only transplantation outcomes in primary hyperoxaluria (PH) are described. Strategies for the selection of type and timing of transplantation and pretransplantation and posttransplantation management are reviewed. Records were reviewed for 16 patients with PH who received 9 liver-kidney and 10 kidney-only transplants. Plasma oxalate values declined from 61 ± 42 μmol/L pretransplantation to 9 ± 6 μmol/L 1 month after transplantation in liver-kidney transplant recipients and 92 ± 19 to 9 ± 5 μmol/L in kidney-only transplant recipients. In most liver-kidney transplant recipients, hyperoxaluria persisted for 6 to 18 months after transplantation. Follow-up was 3.5 ± 4.1 years in liver-kidney and 4.5 ± 6.3 years in kidney-alone transplant recipients. Patient survival rates were 78{\%} for liver-kidney and 89{\%} for kidney-only transplant recipients. No hepatic allografts were lost. Three of 9 liver-kidney and 6 of 10 kidney-alone transplants lost renal allograft function. In those with functioning kidneys, renal clearance was 45.1 ± 19.5 mL/min/1.73 m2 in liver-kidney transplant recipients and 49.5 ± 26.1 mL/min/ 1.73 m2 in kidney-only transplant recipients at last follow-up. Kaplan-Meier 1-, 2-, 3-, and 5-year renal allograft survival rates for patients undergoing transplantation after 1984 were 78{\%}, 78{\%}, 52{\%}, and 52{\%} in liver-kidney transplant recipients and 86{\%}, 71{\%}, 54{\%}, and 36{\%} in kidney-only transplant recipients. Simultaneous grafting of liver and kidney after the development of renal insufficiency is recommended for the majority of patients with PH type I (PH-I). Kidney-alone transplantation is recommended for those with pyridoxine-responsive type I disease because pharmacological therapy allows favorable management of oxalate production in this situation. Kidney-alone transplantation also is recommended for PH type II (PH-II). This disease is less severe than PH-I, and it is currently unknown whether liver transplantation will correct the metabolic defect responsible for PH-II.",
author = "Monico, {Carla G.} and Milliner, {Dawn S.}",
year = "2001",
doi = "10.1053/jlts.2001.28741",
language = "English (US)",
volume = "7",
pages = "954--963",
journal = "Liver Transplantation",
issn = "1527-6465",
publisher = "John Wiley and Sons Ltd",
number = "11",

}

TY - JOUR

T1 - Combined liver-kidney and kidney-alone transplantation in primary hyperoxaluria

AU - Monico, Carla G.

AU - Milliner, Dawn S.

PY - 2001

Y1 - 2001

N2 - Combined liver-kidney and kidney-only transplantation outcomes in primary hyperoxaluria (PH) are described. Strategies for the selection of type and timing of transplantation and pretransplantation and posttransplantation management are reviewed. Records were reviewed for 16 patients with PH who received 9 liver-kidney and 10 kidney-only transplants. Plasma oxalate values declined from 61 ± 42 μmol/L pretransplantation to 9 ± 6 μmol/L 1 month after transplantation in liver-kidney transplant recipients and 92 ± 19 to 9 ± 5 μmol/L in kidney-only transplant recipients. In most liver-kidney transplant recipients, hyperoxaluria persisted for 6 to 18 months after transplantation. Follow-up was 3.5 ± 4.1 years in liver-kidney and 4.5 ± 6.3 years in kidney-alone transplant recipients. Patient survival rates were 78% for liver-kidney and 89% for kidney-only transplant recipients. No hepatic allografts were lost. Three of 9 liver-kidney and 6 of 10 kidney-alone transplants lost renal allograft function. In those with functioning kidneys, renal clearance was 45.1 ± 19.5 mL/min/1.73 m2 in liver-kidney transplant recipients and 49.5 ± 26.1 mL/min/ 1.73 m2 in kidney-only transplant recipients at last follow-up. Kaplan-Meier 1-, 2-, 3-, and 5-year renal allograft survival rates for patients undergoing transplantation after 1984 were 78%, 78%, 52%, and 52% in liver-kidney transplant recipients and 86%, 71%, 54%, and 36% in kidney-only transplant recipients. Simultaneous grafting of liver and kidney after the development of renal insufficiency is recommended for the majority of patients with PH type I (PH-I). Kidney-alone transplantation is recommended for those with pyridoxine-responsive type I disease because pharmacological therapy allows favorable management of oxalate production in this situation. Kidney-alone transplantation also is recommended for PH type II (PH-II). This disease is less severe than PH-I, and it is currently unknown whether liver transplantation will correct the metabolic defect responsible for PH-II.

AB - Combined liver-kidney and kidney-only transplantation outcomes in primary hyperoxaluria (PH) are described. Strategies for the selection of type and timing of transplantation and pretransplantation and posttransplantation management are reviewed. Records were reviewed for 16 patients with PH who received 9 liver-kidney and 10 kidney-only transplants. Plasma oxalate values declined from 61 ± 42 μmol/L pretransplantation to 9 ± 6 μmol/L 1 month after transplantation in liver-kidney transplant recipients and 92 ± 19 to 9 ± 5 μmol/L in kidney-only transplant recipients. In most liver-kidney transplant recipients, hyperoxaluria persisted for 6 to 18 months after transplantation. Follow-up was 3.5 ± 4.1 years in liver-kidney and 4.5 ± 6.3 years in kidney-alone transplant recipients. Patient survival rates were 78% for liver-kidney and 89% for kidney-only transplant recipients. No hepatic allografts were lost. Three of 9 liver-kidney and 6 of 10 kidney-alone transplants lost renal allograft function. In those with functioning kidneys, renal clearance was 45.1 ± 19.5 mL/min/1.73 m2 in liver-kidney transplant recipients and 49.5 ± 26.1 mL/min/ 1.73 m2 in kidney-only transplant recipients at last follow-up. Kaplan-Meier 1-, 2-, 3-, and 5-year renal allograft survival rates for patients undergoing transplantation after 1984 were 78%, 78%, 52%, and 52% in liver-kidney transplant recipients and 86%, 71%, 54%, and 36% in kidney-only transplant recipients. Simultaneous grafting of liver and kidney after the development of renal insufficiency is recommended for the majority of patients with PH type I (PH-I). Kidney-alone transplantation is recommended for those with pyridoxine-responsive type I disease because pharmacological therapy allows favorable management of oxalate production in this situation. Kidney-alone transplantation also is recommended for PH type II (PH-II). This disease is less severe than PH-I, and it is currently unknown whether liver transplantation will correct the metabolic defect responsible for PH-II.

UR - http://www.scopus.com/inward/record.url?scp=0035180928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035180928&partnerID=8YFLogxK

U2 - 10.1053/jlts.2001.28741

DO - 10.1053/jlts.2001.28741

M3 - Article

C2 - 11699031

AN - SCOPUS:0035180928

VL - 7

SP - 954

EP - 963

JO - Liver Transplantation

JF - Liver Transplantation

SN - 1527-6465

IS - 11

ER -